Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s natural defenses. The findings, published in Nature Immunology, could lead to new immunotherapy approaches for treating cancer as well as potential treatments for inflammatory disorders and neurologic diseases.
“Myeloid cells are among the first group of immune cells recruited to tumors, but very quickly these…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply